Significant Challenges Facing HIV Practitioners
Tags: ANTIVIRAL agents; HIV (Viruses)
Related Articles
- HIV wages war on 'miracle' drugs. Cohen, Philip // New Scientist;8/17/2002, Vol. 175 Issue 2356, p22
Reports the need to develop drugs to combat resistance to HIV virus in the U.S. Details on the screening of HIV patients for resistance; Efficacy of antiviral drugs against AIDS; Side effects of antiviral agents.
- Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. del Amo, J.; del Romero, J.; Barrasa, A.; P�rez-Hoyos, S.; Rodr�guez, C.; D�ez, M.; Garc�, S.; Soriano, V.; Castilla, J. // Sexually Transmitted Infections;Aug2002, Vol. 78 Issue 4, p255
Objective: To study HIV progression from seroconversion over a 15 year period and measure the population effectiveness of highly active antiretroviral therapy (HAART). Methods: A cohort study of people with well documented dates of seroconversion. Cumulative risk of AIDS and death were...
- ritonavir:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p193
An encyclopedia entry for ritonavir, which is an HIV protease inhibitor that works by interfering with the reproductive cycle of HIV, is presented.
- Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1. Murphy, Robert L.; Sommadossi, Jean-Pierre; Lamson, Michael; Hall, David B.; Myers, Maureen; Dusek, Alex // Journal of Infectious Diseases;5/1/99, Vol. 179 Issue 5, p1116
Discusses the antiviral effect and pharmacokinetic interaction between Nevirapine and Indinavir in persons infected with human immunodeficiency virus (HIV) type 1. Sevenfold difference among subjects in indinavir area under the curve (AUC); Significant correlation between indinavir AUC, minimum...
- Prevalence of different HIV-1 subtypes in an urban clinic in Madrid. J.C. Mart�n // Sexually Transmitted Infections;Feb2002, Vol. 78 Issue 1, p1
The introduction of non-B HIV-1 variants into Western Europe and North America is of great concern since diagnostic tools and drugs are mainly optimised for targeting HIV-1 subtype B viruses. Madrid is an endemic area for HIV, and either the final destination or transient location for many...
- Antiviral briefs. // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p229
Presents news briefs in relation to acquired immunodeficiency syndrome (AIDS) and human immunodeficiency virus (HIV) patients care and sexually transmitted diseases (STDs). Findings on the use of ranitidine for HIV infection; Views of doctor Paul A. Volberding of the University of California at...
- Suitable Monitoring Approaches to Antiretroviral Therapy in Resource-Poor Settings: Setting the Research Agenda. Kent, David M.; McGrath, Donnie; Loannidis, John P. A.; Bennish, Michael L. // Clinical Infectious Diseases;7/1/2003 Supplement 1, Vol. 37, pS13
The delivery of antiretroviral therapy in the developing world requires guidelines for the appropriate monitoring of therapy, including monitoring for treatment effectiveness and treatment failure, drug toxicities, adherence to therapy, and the emergence of resistant organisms. Guidelines...
- CD8[sup +] Cell-Derived Anti-Human Immunodeficiency Virus Inhibitory Factor. Baker, Edward // Journal of Infectious Diseases;5/15/99 Supplement 3, Vol. 179, pS485
Discusses the role and mechanism of the soluble factor CD8[sup +] cell antiviral factor (CAF) in suppressing HIV replication in infected cells. Control of replication in a noncytotoxic manner; Interruption of the ability of Tat or host cellular factors to interact with the HIV long terminal...
- Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B... Dore, Gregory J.; Cooper, David A.; Barrett, Catherine; Li-Ean Goh; Thakrar, Bharat; Atkins, Mark // Journal of Infectious Diseases;9/1/99, Vol. 180 Issue 3, p607
Examines the efficacy and safety of lamivudine in persons coinfected with HIV type 1 and hepatitis B virus (HBV) using a coinfected persons in a randomized, controlled study. Drugs added to lamivudine under the treatment process used in the study; Effect of coinfection with HIV type 1 on HBV...
